6609.HK
Shanghai HeartCare Medical Technology Corporation Limited

Healthcare · Medical Devices · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

162.02M USD

Market Cap

265.95M USD

Margin of Safety

-64.1%

Intrinsic / Market Ratio

0.61×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

162.02M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

162.02M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

162.02M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

162.02M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

162.02M USD

from the sum above

Market Cap

265.95M USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.61×

the ratio the screener ranks by; Margin of Safety -64.1% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 162.02M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).

The earnings power value was not computed (a normalized NOPAT at or below zero), so the value is the book value today, 162.02M USD.

Market value

Market Cap265.95M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-64.2%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 162.02M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.

The projection was not made (a profit at or below zero in the latest three years), so the value is the book value today, 162.02M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFE

Not in the value

②Equity at Year 15, Today

Not in the value

Market value

Market Cap265.95M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-64.2%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 162.02M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (an operating profit at or below zero in the latest three years), so the value is the book value today, 162.02M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Cash Today

Not in the value

Market value

Market Cap265.95M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-64.2%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 7.91%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.58×Market Risk Premium 6.00%= 7.99%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 439.68K USDPretax Income 12.36M USD= 3.56%

The tax the interest saves.

Interest Expense =EBIT 12.66M USD−Pretax Income 12.36M USD= 295.03K USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 295.03K USDTotal Debt 6.11M USD×(1 − Tax Rate for WACC 3.56%)= 4.66%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 6.11M USDMarket Cap + Total Debt 265.95M USD + 6.11M USD= 2.25%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 97.75%×Cost of Equity 7.99%+Debt Weight 2.25%×Cost of Debt 4.66%= 7.91%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2025-12-31.

Total Assets 184.89M USD − Total Liabilities 22.87M USD = Book Value Today 162.02M USD

Total Debt 6.11M USD − Cash and Short-Term Investments 112.53M USD = Net Debt Today -106.42M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-3.0%at most 5%passes37,681,058 / 38,834,408
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets5.5%at least -10.0%passes(22.05M USD − 11.92M USD) ÷ 184.89M USD
Price to bookMarket Cap ÷ Book Value Today1.64×at most 3×passes265.95M USD ÷ 162.02M USD
Operating marginOperating Income ÷ Revenue19.1%above 10.0%passes11.13M USD ÷ 58.42M USD
Revenue growthRevenue ÷ Revenue a Year Before − 153.3%above 10.0%passes58.42M USD / 38.12M USD
Net cash(Cash − Total Debt) ÷ Market Cap29.4%above -30%passes(84.37M USD − 6.11M USD) ÷ 265.95M USD
Operating efficiencyOperating Income ÷ Gross Profit26.9%above 25.0%passes11.13M USD ÷ 41.42M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

52.35 HKD

Enterprise value

1.25B HKD

the provider's own figure

EV / EBITDA

11.41×

Price / book

1.37×

the provider's book

Price / earnings

18.88×

Return on equity

8.0%

the provider's figure, not this page's

Profit margin

18.1%

Revenue growth

56.9%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

26.31M32.72M38.12M58.42M

Gross profit

17.87M23.06M24.92M41.42M

Operating income

-26.66M-14.47M-855.32K11.13M

EBITDA

operating income before depreciation and amortisation

-24.05M-9.65M3.00M16.71M

Pretax income

-28.93M-14.50M-1.64M12.36M

Net income

-28.81M-13.24M-1.87M11.92M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

-28.73M-11.88M-1.39M10.89M

R&D

22.09M17.44M8.08M5.83M
Balance sheet, year end

Total assets

188.69M169.19M165.45M184.89M

Total liabilities

21.14M17.69M19.75M22.87M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

167.55M151.50M145.70M162.02M

Total debt

7.29M5.12M4.90M6.11M

Cash and equivalents

125.09M87.64M82.56M84.37M

Net PP&E

fixed assets after depreciation

18.05M14.04M11.19M11.58M

Working capital

current assets less current liabilities

153.03M133.19M129.12M142.02M
Cash flow

Operating cash flow

-38.35M-12.45M-443.57K22.05M

Capital expenditure

paid out, so below zero

-5.35M-6.95M-707.19K-2.03M

Depreciation and amortisation

4.57M4.54M4.40M4.05M

Free cash flow

operating cash flow plus capital expenditure

-43.70M-19.40M-1.15M20.03M